January 8, 2025
Emerging Clinical-Stage Neuroscience Company Nuvie Bio Announces Positive Phase 1 Data with its Lead Migraine Program
Contact
​
Brian Rosenberger
Senior Vice President, Business Development
media@nuviebio.com
1-888-420-7050